burnaid gel
mundipharma new zealand ltd - melaleuca oil 4%{relative} (+ manufacturing overage of 0.125%) - topical gel - 40 mg/g - active: melaleuca oil 4%{relative} (+ manufacturing overage of 0.125%) excipient: carbomer polysorbate 20 propylene glycol purified water triclosan trolamine
cosopt preservative free
mundipharma new zealand ltd - dorzolamide hydrochloride 22.26 mg/ml equivalent to dorzolamide 20 mg/ml; timolol maleate 6.83 mg/ml equivalent to timolol 5 mg/ml - eye drops, solution - 20 mg/ml, 5 mg/ml - active: dorzolamide hydrochloride 22.26 mg/ml equivalent to dorzolamide 20 mg/ml timolol maleate 6.83 mg/ml equivalent to timolol 5 mg/ml excipient: hyetellose mannitol sodium citrate sodium hydroxide water for injection - cosopt preservative free is indicated for the treatment of elevated intraocular pressure (iop) in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma · or other secondary open-angle glaucoma's and who are: · insufficiently responsive to topical beta blocker monotherapy · currently receiving concomitant antiglaucoma therapies such as dorzolamide hci and timolol maleate
zevalin
mundipharma new zealand ltd - ibritumomab tiuxetan 1.6 mg/ml - concentrate for infusion - 1.6 mg/ml - active: ibritumomab tiuxetan 1.6 mg/ml excipient: sodium chloride water for injection sodium acetate trihydrate water for injection albumin dibasic sodium phosphate dodecahydrate hydrochloric acid as 1n soln, ph adjustment monobasic potassium phosphate pentetic acid potassium chloride sodium chloride sodium hydroxide as 1n soln, ph adjustment water for injection - zevalin is indicated for the treatment of adult patients with cd20 positive indolent b-cell non-hodgkin's lymphoma (nhl) who have failed rituximab therapy.
oxycontin 10mg prolonged release tablets
mundipharma pharmaceuticals pte. ltd. - oxycodone hydrochloride - tablet, film coated, extended release - 10mg - oxycodone hydrochloride 10mg
oxycontin 20mg prolonged release tablets
mundipharma pharmaceuticals pte. ltd. - oxycodone hydrochloride - tablet, film coated, extended release - 20mg - oxycodone hydrochloride 20mg
oxycontin 40mg prolonged release tablets
mundipharma pharmaceuticals pte. ltd. - oxycodone hydrochloride - tablet, film coated, extended release - 40mg - oxycodone hydrochloride 40mg
oxycontin 5mg prolonged release tablets
mundipharma pharmaceuticals pte. ltd. - oxycodone hydrochloride - tablet, film coated, extended release - 5mg - oxycodone hydrochloride 5mg
oxycontin 80mg prolonged release tablets
mundipharma pharmaceuticals pte. ltd. - oxycodone hydrochloride - tablet, film coated, extended release - 80.00mg - oxycodone hydrochloride 80.00mg
oxynorm 20mg capsule
mundipharma pharmaceuticals pte. ltd. - oxycodone hydrochloride - capsule - 20mg - oxycodone hydrochloride 20mg
mundipharma betadine repigel™
mundipharma pharmaceuticals pte. ltd. - general hospital - betadine® repigel™ promotes wound healing. it is generally suitable for wounds from a wide range of causes and is particularly suitable for the treatment of wounds where there is a risk of infection.